The Healgen Rapid COVID-19 Antigen test has been trialled and tested by Public Health England. The Healgen Test is an in vitro immunochromatographic assay for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in direct nasopharyngeal (NP) swab from individuals who are suspected of COVID-19. It is intended to aid in the rapid diagnosis of SARS-CoV-2 infections.
The point of care test is designed for use by clinical specialists and healthcare professionals only.
The test is taken to:
⦁ Diagnose infection
⦁ Test following infection to see if the virus has been cleared
⦁ Screen asymptomatic individuals to detect if they carry virus and are potentially infectious